Radiopharm Theranostics Limited

ASX:RAD Stock Report

Market Cap: AU$60.8m

Radiopharm Theranostics Management

Management criteria checks 2/4

Radiopharm Theranostics' CEO is Riccardo Canevari, appointed in Sep 2021, has a tenure of 3.08 years. total yearly compensation is A$2.65M, comprised of 31.8% salary and 68.2% bonuses, including company stock and options. directly owns 0.62% of the company’s shares, worth A$375.30K. The average tenure of the management team and the board of directors is 2.7 years and 2.5 years respectively.

Key information

Riccardo Canevari

Chief executive officer

AU$2.7m

Total compensation

CEO salary percentage31.8%
CEO tenure3.1yrs
CEO ownership0.6%
Management average tenure2.7yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

We're A Little Worried About Radiopharm Theranostics' (ASX:RAD) Cash Burn Rate

Jan 06
We're A Little Worried About Radiopharm Theranostics' (ASX:RAD) Cash Burn Rate

Here's Why Radiopharm Theranostics (ASX:RAD) Must Use Its Cash Wisely

Sep 02
Here's Why Radiopharm Theranostics (ASX:RAD) Must Use Its Cash Wisely

CEO Compensation Analysis

How has Riccardo Canevari's remuneration changed compared to Radiopharm Theranostics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$3mAU$844k

-AU$48m

Mar 31 2024n/an/a

-AU$47m

Dec 31 2023n/an/a

-AU$47m

Sep 30 2023n/an/a

-AU$41m

Jun 30 2023AU$3mAU$825k

-AU$35m

Mar 31 2023n/an/a

-AU$30m

Dec 31 2022n/an/a

-AU$26m

Sep 30 2022n/an/a

-AU$28m

Jun 30 2022AU$3mAU$631k

-AU$30m

Compensation vs Market: Riccardo's total compensation ($USD1.78M) is above average for companies of similar size in the Australian market ($USD304.18K).

Compensation vs Earnings: Riccardo's compensation has been consistent with company performance over the past year.

CEO

Riccardo Canevari

3.1yrs

Tenure

AU$2,652,983

Compensation

Mr. Riccardo Canevari is Managing Director & Chief Executive Officer since September 13, 2021 and Director at Radiopharm Theranostics Limited. He was Chief Commercial Officer of Advanced Accelerator Applic...

Leadership Team

NamePositionTenureCompensationOwnership
Paul Hopper
Founder & Executive Chairman3.7yrsAU$478.85k6.87%
A$ 4.2m
Riccardo Canevari
MD, CEO & Director3.1yrsAU$2.65m0.62%
A$ 375.3k
Phillip Hains
CFO, Company Secretary & Directorno dataAU$27.71k0.73%
A$ 446.8k
Vittorio Puppo
Chief Operating Officer2.3yrsAU$1.60mno data
Thomas Tulip
Chief Business Officerno dataAU$579.19k0.046%
A$ 28.0k
Dimitris Voliotis
Chief Medical Officerless than a yearno datano data
Nathan Jong
Company Secretary3yrsno datano data

2.7yrs

Average Tenure

68yo

Average Age

Experienced Management: RAD's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Paul Hopper
Founder & Executive Chairman3.7yrsAU$478.85k6.87%
A$ 4.2m
Riccardo Canevari
MD, CEO & Directorno dataAU$2.65m0.62%
A$ 375.3k
Phillip Hains
CFO, Company Secretary & Directorless than a yearAU$27.71k0.73%
A$ 446.8k
Eric Aboagye
Member of Scientific Advisory Boardno datano datano data
Ian Turner
Non-Executive Director3.5yrsAU$476.52k0.21%
A$ 129.4k
Leila Alland
Non-Executive Director2.3yrsAU$165.41k0.049%
A$ 30.0k
Sara A. Hurvitz
Member of Scientific Advisory Boardno datano datano data
Hoi Hong
Member of Scientific Advisory Boardno datano datano data
Johannes Notni
Member of Scientific Advisory Boardno datano datano data
David Ulmert
Member of Scientific Advisory Boardno datano datano data
Hester Larkin
Non-Executive Director2.7yrsAU$94.32k0.030%
A$ 18.0k
Susann Brady-Kalnay
Member of Scientific Advisory Board2.3yrsno datano data

2.5yrs

Average Tenure

Experienced Board: RAD's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.